Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Cash flows from operating activities:      
Net income $ 5,601 $ 8,955 $ 3,516
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization expense 125,742 126,114 123,362
Loss on extinguishment of debt (9,111) 0 0
Deferred income tax expense 7,485 9,488 3,936
Share-based compensation expense 6,620 6,733 2,804
Other noncash income and expense items 8,555 6,725 14,919
Change in operating assets and liabilities (28,680) 13,244 (47,618)
Net cash provided by operating activities 134,434 171,259 100,919
Cash flows from investing activities:      
Purchases of property and equipment (177,090) (96,194) (120,983)
Grant proceeds 35,060 0 0
Restricted cash (16,621) 0 0
Insurance proceeds 233 990 0
Purchase of businesses, net of cash received (352) (5,545) (109)
Purchase of marketable securities 0 941 (305)
Proceeds from sale of marketable securities 0 (202) 613
Purchases of other assets and intangible assets (5,423) (4,712) (5,093)
Net cash used in investing activities (164,193) (104,722) (125,877)
Cash flows from financing activities:      
Repayment of debt and capital lease obligations (429,626) (35,974) (402,710)
Issuance of Senior Notes 325,000 0 421,473
Borrowing on Senior Credit Facility 142,000 30,000 30,000
Purchase of treasury stock to be retired (55,661) (80,807) 0
Borrowing of other long-term debt 35,201 6,206 3,884
Investment by non-controlling interest 16,546 0 0
Payment of Senior Notes call premiums (4,728) 0 0
Payment of debt issuance costs (3,603) (2,300) (9,006)
Other 947 632 189
Net cash provided by (used in) financing activities 26,076 (82,243) 43,830
Net (decrease) increase in cash and cash equivalents (3,683) (15,706) 18,872
Cash and cash equivalents at beginning of period 33,070 48,776 29,904
Cash and cash equivalents at end of period $ 29,387 $ 33,070 $ 48,776